Sp. Pereira et al., Octreotide increases the proportions of arachidonic acid-rich phospholipids in gall-bladder bile, ALIM PHARM, 15(9), 2001, pp. 1435-1443
Background and aims: Octreotide treatment of acromegalic patients induces c
holesterol gallstone formation, in part by impairing cholecystokinin releas
e and gallbladder contraction. However, there are few data on the effect of
octreotide on biliary arachidonic acid-rich phospholipids or mucin glycopr
otein, factors which also influence cholesterol gallstone formation.
Methods: In acromegalic patients studied before and during 3 months of octr
eotide treatment, we measured mucin glycoprotein concentrations and the mol
ecular species of phosphatidylcholine, and related the results to the chole
sterol saturation and percentage of deoxycholic acid in gall-bladder bile.
Results: The relative proportions of the major arachidonic acid-rich phosph
atidylcholine species, PC 16:0-20:4 and PC 18:0-20:4, increased significant
ly during octreotide treatment. These changes were associated with a rise i
n the cholesterol saturation index and a non-significant twofold increase i
n mucin glycoprotein concentration. There were significant correlations bet
ween PC 16:0-20:4 and the cholesterol saturation index, percentage of vesic
ular cholesterol and percentage of deoxycholic acid in gall-bladder bile.
Conclusions: In acromegalic patients, octreotide increases the proportions
of arachidonic acid-rich phospholipids, with associated rises in: (a) the c
holesterol saturation index and percentage of vesicular cholesterol, and (b
) the percentage of deoxycholic acid in gallbladder bile-changes similar to
those found in patients with cholesterol-rich gall-bladder stones.